Attached files
| file | filename |
|---|---|
| EX-32.1 - CERTIFICATION - Phio Pharmaceuticals Corp. | phio_ex3201.htm |
| EX-31.1 - CERTIFICATION - Phio Pharmaceuticals Corp. | phio_ex3101.htm |
| EX-4.13 - DESCRIPTION OF THE REGISTRANT S SECURITIES - Phio Pharmaceuticals Corp. | phio_ex0413.htm |
| 10-K - FORM 10-K - Phio Pharmaceuticals Corp. | phio_10k-123119.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Phio Pharmaceuticals Corp.
Marlborough, Massachusetts
We hereby consent to the incorporation by reference in the Registration Statements on Forms S-8 (Nos. 333-183633, 333-189521, 333-189522, 333-215870, 333-215871, 333-227013, 333-2350547 and 333-236784) and Form S-3 (No. 333-224031) of Phio Pharmaceuticals Corp. of our report dated March 26, 2020, relating to the consolidated financial statements, which appears in this Form 10-K.
/s/ BDO USA, LLP
Boston, Massachusetts
March 26, 2020